phekolo ea kankere ea matšoafo ea phetoho ea liphatsa tsa lefutso

Ho utloisisa karolo ea phekolo ea kankere ea matšoafo ea phetoho ea liphatsa tsa lefutso e bohlokoa bakeng sa taolo ea mofetše oa matšoafo ka motho ka mong. Sengoliloeng sena se hlahloba hore na tlhahlobo ea liphatsa tsa lefutso e tsebisa joang liqeto tsa phekolo, mefuta ea liphetoho tse atisang ho fumanoa mofetšeng oa matšoafo, le mekhoa ea phekolo e lebisitsoeng ho liphetoho tsena tse khethehileng. phekolo ea kankere ea matšoafo ea phetoho ea liphatsa tsa lefutso. Liphetoho tsena li ka hlaha liphatseng tsa lefutso tse laolang khōlo ea lisele, karohano le ho lokisoa. Ho khetholla liphetoho tsena ho bohlokoa hobane ho ka tataisa mekhoa ea phekolo le ho ntlafatsa liphello tsa mokuli. Setsing sa Lipatlisiso sa Kankere sa Shandong Baofa, re etelletsa pele ho utloisisa boemo ba lefutso la mofetše oa matšoafo oa mokuli e mong le e mong. Liphetoho tsa lefutso ke life?Phekolo ea liphatsa tsa lefutso tsa mofetše oa matšoafo ke liphetoho tsa tatellano ea DNA tse ka lebisang boitšoarong bo sa tloaelehang ba lisele. Liphetoho tsena li ka futsa kapa tsa fumanoa nakong ea bophelo ba motho. Kankere ea matšoafo, liphetoho tse fumanoeng li atile haholo 'me hangata li bakoa ke maemo a tikoloho joalo ka ho tsuba kapa ho pepesehela lintho tse silafatsang. Liphetoho tsena li ka senya mekhoa e tloaelehileng ea lisele, e leng se lebisang khōlong e sa laoleheng le ho thehoa ha lihlahala.Liphetoho tse tloaelehileng tsa liphatsa tsa lefutso ho Kankere ea MatšoafoLiphatsa tsa lefutso tse ngata li atisa ho fetoloa mofetšeng oa matšoafo. Ho utloisisa liphetoho tsena ho bohlokoa bakeng sa ho khetha mokhoa o nepahetseng oa kalafo. Tse ling tsa tse atileng haholo ke tsena:EGFR (Epidermal Growth Factor Receptor): Liphetoho ho EGFR li tloaelehile ho kankere e seng e nyane ea lisele tsa matšoafo (NSCLC), haholo-holo ho adenocarcinomas. Liphetoho tsena li ka etsa hore lisele tsa mofetše li amehe haholo ho liphekolo tse itseng tse reretsoeng.ALK (Anaplastic Lymphoma Kinase): Litokiso tsa ALK ke phetoho e 'ngoe e ka lebelloang e fumanehang ho NSCLC. ALK inhibitors e bontšitse katleho e kholo ho phekoleng lihlahala ka phetoho ena.ROS1: Joalo ka ALK, li-fusion tsa ROS1 li ka tsamaisa kholo ea mofetše oa matšoafo. ROS1 inhibitors lia fumaneha bakeng sa bakuli ba nang le ROS1-positive NSCLC.BRAF: Liphetoho tsa BRAF, haholo-holo phetoho ea V600E, li ka fumanoa ho NSCLC. Li-inhibitor tsa BRAF li ka sebelisoa ho shebana le liphetoho tsena.KRAS: Liphetoho tsa KRAS li tloaelehile ho lung adenocarcinoma. Le ha ho le thata ho tsepamisa maikutlo nalaneng, litlhare tse ncha li ntse li hlaha ho phekola mofetše oa matšoafo o fetotsoeng oa KRAS.PD-L1 (Lefu-Ligand 1 e hlophisitsoeng): Le hoja e se phetoho ea liphatsa tsa lefutso ka mokhoa oa setso, polelo ea PD-L1 ke biomarker e ka bolelang esale pele karabelo ho immunotherapy. Polelo e phahameng ea PD-L1 e ka bontša hore mokuli a ka rua molemo ho immunotherapy.Tlhahlobo ea Liphatsa tsa lefutso bakeng sa Kankere ea MatšoafoPhekolo ea liphatsa tsa lefutso tsa mofetše oa matšoafo e tsejoa ka tlhahlobo e felletseng ea liphatsa tsa lefutso, tse tsejoang hape e le tlhahlobo ea biomarker kapa profiling ea limolek'hule. Teko ena e sekaseka lisele tsa tumor kapa, maemong a mang, lisampole tsa mali ho tseba liphetoho tse itseng tsa lefutso tse tsamaisang kholo ea mofets'e. Liphetho tsa liteko tsena li thusa li-oncologists ho iketsetsa merero ea kalafo ho shebana le litšobotsi tse ikhethang tsa mofetše oa mokuli e mong le e mong. Setsi sa Patlisiso sa Kankere sa Baofa se sebelisa mekhoa ea morao-rao ea tlhahlobo ea lefutso.Mefuta ea Liteko tsa Liphatsa tsa lefutsoMefuta e mengata ea liteko tsa lefutso e sebelisoa tlhahlobong ea mofetše oa matšoafo le moralong oa kalafo:Latelano ea Meloko e Tlang (NGS): NGS ke mokhoa o felletseng oa tlhahlobo o ka sekasekang liphatsa tsa lefutso tse ngata ka nako e le 'ngoe. Sena se lumella ho lemoha mefuta e mengata ea liphetoho le liphetoho tse ling tsa genomic.Polymerase Chain Reaction (PCR): PCR ke mokhoa o tsepamisitsoeng haholo oa tlhahlobo o sebelisetsoang ho bona liphetoho tse itseng kapa tlhophiso ea liphatsa tsa lefutso.Fluorescence In Situ Hybridization (FISH): FISH e sebelisoa ho lemoha tlhophiso ea liphatsa tsa lefutso, joalo ka ALK le ROS1 fusions.Immunohistochemistry (IHC): IHC e sebelisetsoa ho lemoha polelo ea protheine, e kang PD-L1, e ka thusang ho bolela esale pele karabelo ho immunotherapy.Na ho Lokela ho Etsoa Teko ea Liphatsa tsa lefutso?Teko ea liphatsa tsa lefutso e lokela ho etsoa ho bakuli bohle ba fumanoang ba e-na le NSCLC e tsoetseng pele. Tlhahlobo e lokela ho etsoa kapele kamoo ho ka khonehang ts'ebetsong ea moralo oa phekolo e le hore mekhoa ea phekolo e lebisitsoeng e ka nahanoa ho tloha qalong. Ho bohlokoa hape ho etsa liteko hape haeba mofetše o ntse o tsoela pele kapa ho na le mekhoa e mecha ea phekolo. phekolo ea kankere ea matšoafo ea phetoho ea liphatsa tsa lefutso. Litlhare tsena li etselitsoe ho kena-kenana le kholo, karohano le ho ata ha lisele tsa mofetše ha li ntse li fokotsa tšenyo ea lisele tse tloaelehileng. Mokhoa oa phekolo oa motho ka mong oa Sepetlele sa Baofa o sebelisa mekhoa e tsoetseng pele haholo ea ho phekola. Lithethefatsi tsena li thibela tšebetso ea protheine ea EGFR, eo hangata e sebetsang ka ho fetelletseng liseleng tsa mofetše ka liphetoho tsena. Li-inhibitors tse tloaelehileng tsa EGFR li kenyelletsa:Gefitinib (Iressa)Erlotinib (Tarceva)Afatinib (Gilotrif)Osimertinib (Tagrisso): Hangata kalafo ea mothapo oa pele bakeng sa EGFR-mutated NSCLC.ALK InhibitorsALK inhibitors e sebelisoa ho phekola mofetše oa matšoafo ka litlhophiso tsa ALK. Lithethefatsi tsena li thibela tšebetso ea protheine ea ALK, eo hangata e sebetsang ka mokhoa o sa tloaelehang liseleng tsa mofetše ka ho hlophisa bocha. Li-inhibitors tse tloaelehileng tsa ALK li kenyelletsa:Crizotinib (Xalkori)Alectinib (Alecensa)Ceritinib (Zykadia)Brigatinib (Alunbrig)Lorlatinib (Lorbrena)ROS1 InhibitorsROS1 inhibitors e sebelisoa ho phekola mofetše oa matšoafo ka motsoako oa ROS1. Lithethefatsi tsena li thibela tšebetso ea protheine ea ROS1, eo hangata e sebetsang ka mokhoa o sa tloaelehang liseleng tsa mofetše ka li-fusion tsena. Li-inhibitors tse tloaelehileng tsa ROS1 li kenyelletsa:Crizotinib (Xalkori)Entrectinib (Rozlytrek)BRAF Inhibitors BRAF inhibitors e sebelisoa ho phekola mofetše oa matšoafo ka liphetoho tsa BRAF, haholo-holo phetoho ea V600E. Lithethefatsi tsena li thibela tšebetso ea protheine ea BRAF, eo hangata e sebetsang ho feta tekano liseleng tsa mofetše ka liphetoho tsena. Li-inhibitors tse tloaelehileng tsa BRAF li kenyelletsa:Dabrafenib (Tafinlar)Trametinib (Mekinist): Hangata e sebelisoa hammoho le dabrafenib.KRAS G12C InhibitorsSotorasib (Lumakras) le Adagrasib (Krazati) ke mehlala ea li-inhibitors tsa KRAS G12C tse sebelisoang ho phekola kankere ea matšoafo ka phetoho ena e khethehileng ea KRAS. Li sebetsa ka ho thibela tšebetso ea protheine ea KRAS e fetotsoeng.Immunotherapy le Genetic MutationsImmunotherapy ke mofuta oa phekolo ea mofetše o thusang sesole sa' mele ho loantša mofetše. Le hoja immunotherapy e sa shebane ka ho toba phekolo ea kankere ea matšoafo ea phetoho ea liphatsa tsa lefutso, liphetoho tse itseng tsa lefutso le li-biomarker, tse kang polelo ea PD-L1 le tumor mutational burden (TMB), li ka bolela esale pele karabelo ho immunotherapy. Bakuli ba nang le polelo e phahameng ea PD-L1 kapa TMB e phahameng ba ka ba le monyetla oa ho rua molemo ho immunotherapy. Setsing sa Lipatlisiso sa Kankere sa Shandong Baofa, re kopanya immunotherapy le mekhoa e meng ea phekolo bakeng sa mokhoa o pharaletseng.Bokamoso ba Kalafo ea Kankere ea MatšoafoLebala la phekolo ea kankere ea matšoafo le fetoha ka potlako. Mekhoa e mecha ea phekolo le immunotherapies e ntse e ntlafatsoa le ho lekoa litekong tsa meriana. Bafuputsi le bona ba ntse ba sebeletsa ho fumana tse ncha phekolo ea kankere ea matšoafo ea phetoho ea liphatsa tsa lefutso e ka lebisoang ho liphekolo tse ncha. Ha kutloisiso ea rona ea liphatsa tsa lefutso tsa mofetše oa matšoafo e ntse e ntlafala, re ka lebella ho bona mekhoa ea kalafo e ikhethileng le e sebetsang bakeng sa bakuli. Setsi sa Lipatlisiso sa Kankere sa Shandong Baofa se ikemiselitse ho lula ka pele ho tsoelo-pele ena.Lethathamo la Lits'oants'o: Liphekolo Tse Lebisitsoeng Ho Thehiloe ho Phetoho e Lebeletsoeng ea PhetohoTlhalosoEGFROsimertinib, Gefitinib, Erlotinib, AfatinibBlock EGFR protein activityALKAlectinib, Crizotinib, BrilagabKK protheine. mosebetsiROS1Crizotinib, EntrectinibThibela tšebetso ea protheine ea ROS1BRAF V600EDabrafenib (hangata e nang le Trametinib)Thibela tšebetso ea protheine ea BRAFKRAS G12CSotorasib, AdagrasibLoloko e fetotsoeng tšebetso ea protheine ea KRASQetelloHo utloisisa karolo ea phekolo ea kankere ea matšoafo ea phetoho ea liphatsa tsa lefutso e bohlokoa bakeng sa ho ntlafatsa liphetho ho bakuli ba nang le mofetše oa matšoafo. Teko ea liphatsa tsa lefutso e ka thusa ho tseba liphetoho tse itseng tse ka lebisoang ho liphekolo tsa motho ka mong. Ha kutloisiso ea rona ea liphatsa tsa lefutso tsa mofetše oa matšoafo e ntse e hola, re ka lebella ho bona liphekolo tse sebetsang le tse lebisitsoeng ho lefu lena le senyang. Etela Setsi sa Lipatlisiso sa Kankere sa Shandong Baofa ho ithuta haholoanyane ka mokhoa oa rona o felletseng oa tlhokomelo ea mofetše oa matšoafo.Boitlhaloso: Lintlha tsena ke tsa merero ea thuto feela 'me ha lia lokela ho nkoa e le keletso ea bongaka. Kamehla buisana le setsebi se tšoanelehang sa tlhokomelo ea bophelo bakeng sa tlhahlobo le kalafo ea maemo a bongaka.ReferencesNational Cancer Institute. www.cancer.govMokhatlo oa Amerika oa Kankere. www.cancer.org